Compare IART & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IART | STAA |
|---|---|---|
| Founded | 1989 | 1982 |
| Country | United States | United States |
| Employees | 4427 | N/A |
| Industry | Medical/Dental Instruments | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 867.9M |
| IPO Year | 1996 | 1995 |
| Metric | IART | STAA |
|---|---|---|
| Price | $15.09 | $32.54 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 9 |
| Target Price | $14.33 | ★ $22.81 |
| AVG Volume (30 Days) | ★ 1.1M | 874.7K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | $4.39 | $30.82 |
| Revenue Next Year | $3.40 | $8.41 |
| P/E Ratio | ★ N/A | $328.05 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.70 | $15.59 |
| 52 Week High | $16.42 | $35.87 |
| Indicator | IART | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 70.06 | 77.35 |
| Support Level | $12.64 | $23.75 |
| Resistance Level | $16.35 | $35.87 |
| Average True Range (ATR) | 0.91 | 1.50 |
| MACD | 0.11 | 0.25 |
| Stochastic Oscillator | 90.11 | 66.12 |
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.